Mucormycosis of Paranasal Sinuses of Odontogenic Origin Post COVID19 Infection: A Case Series

被引：14

作者：

Saidha, Poonam Kumar ^{[1
]}

Kapoor, Sahil ^{[1
]}

Das, Pooja ^{[1
]}

Gupta, Ayushi ^{[1
]}

Kakkar, Vikas ^{[1
]}

Kumar, Arun ^{[1
]}

Arya, Varun ^{[1
]}

机构：

[1] SGT Univ, Dept ENT, SGT Hosp, Gurgaon, India

来源：

INDIAN JOURNAL OF OTOLARYNGOLOGY AND HEAD & NECK SURGERY | 2022年 / 74卷 / SUPPL 2期

关键词：

Mucormycosis; Type 2 diabetes mellitus; Immunocompromised; COVID-19; Amphotericin B; PULMONARY ASPERGILLOSIS; CLINICAL-FEATURES;

D O I：

10.1007/s12070-021-02638-1

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The Severe acute respiratory syndrome and the Middle East respiratory syndromes emerged in 2002 and 2012 respectively. Currently the world is witnessing a global pandemic caused by a novel coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS CoV- 2) causing the Coronavirus 2019 (COVID-19). Mucormycosis is a fungal infection primarily affecting individuals with an immunocompromised state like diabetes mellitus, malignancies etc. Patients who have or have had COVID-19 infection with pre-existing uncontrolled Type 2 Diabetes mellitus are presumably more vulnerable for emergence of fungal infections cases. This article presents a report of 6 cases with histopathological proven mucormycosis associated with COVID-19 and uncontrolled Diabetes mellitus.

引用

页码：3437 / 3441

页数：5

共 19 条

[1] Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19 [J].

Alanio, Alexandre ;

Delliere, Sarah ;

Fodil, Sofiane ;

Bretagne, Stephane ;

Megarbane, Bruno .

LANCET RESPIRATORY MEDICINE, 2020, 8 (06) :E48-E49

[2] COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment [J].

Arastehfar, Amir ;

Carvalho, Agostinho ;

van de Veerdonk, Frank L. ;

Jenks, Jeffrey D. ;

Koehler, Philipp ;

Krause, Robert ;

Cornely, Oliver A. ;

Perlin, David S. ;

Lass-Floerl, Cornelia ;

Hoenigl, Martin .

JOURNAL OF FUNGI, 2020, 6 (02) :1-17

[3] Invasive mould infections in the ICU setting: complexities and solutions [J].

Bassetti, Matteo ;

Bouza, Emilio .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 :I39-I47

[4] Antifungal susceptibility testing practices in mycology laboratories in France, 2018 [J].

Bellanger, A-P ;

Persat, F. ;

Foulet, F. ;

Bonnal, C. ;

Accoceberry, I ;

Angebault, C. ;

Angoulvant, A. ;

Augereau, O. ;

Bailly, E. ;

Bert, F. ;

Bonhomme, J. ;

Bouchara, J-P ;

Bougnoux, M-E ;

Bourdeau, P. ;

Bouteille, B. ;

Brun, S. ;

Brunet, K. ;

Camin-Ravenne, A-M ;

Cassaing, S. ;

Chouaki, T. ;

Cornet, M. ;

Costa, D. ;

Desbois, N. ;

Dorin, J. ;

Fekkar, A. ;

Fiacre, A. ;

Frealle, E. ;

Gangneux, J-P ;

Guillot, J. ;

Guitard, J. ;

Hasseine, L. ;

Huguenin, A. ;

Lachaud, L. ;

Larreche, S. ;

Lavergne, R-A ;

Le Gal, S. ;

Le Govic, Y. ;

Letscher-Bru, V ;

Machouart, M. ;

Mazars, E. ;

Nourrisson, C. ;

Paugam, A. ;

Ranque, S. ;

Risco-Castillo, V ;

Sasso, M. ;

Sautour, M. ;

Sendid, B. ;

Senghor, Y. ;

Botterel, F. ;

Dannaoui, Eric .

JOURNAL DE MYCOLOGIE MEDICALE, 2020, 30 (02)

[5] Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient [J].

Blaize, Marion ;

Mayaux, Julien ;

Nabet, Cecile ;

Lampros, Alexandre ;

Marcelin, Anne-Genevieve ;

Thellier, Marc ;

Piarroux, Renaud ;

Demoule, Alexandre ;

Fekkar, Arnaud .

EMERGING INFECTIOUS DISEASES, 2020, 26 (07) :1636-1637

[6] Mucormycosis:: an emerging disease? [J].

Bouza, E. ;

Munoz, P. ;

Guinea, J. .

CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 :7-23

[7] MUCORMYCOSIS OF THE MANDIBLE [J].

BROWN, OE ;

FINN, R .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1986, 44 (02) :132-136

[8]

Fogarty C, 2006, J CAN DENT ASSOC, V72, P149

[9] Invasive fungal diseases during COVID-19: We should be prepared [J].

Gangneux, J. -P. ;

Bougnoux, M. -E. ;

Dannaoui, E. ;

Cornet, M. ;

Zahar, J. R. .

JOURNAL DE MYCOLOGIE MEDICALE, 2020, 30 (02)

[10]

Greenberg MS., 2003, Burket's Oral Medicine, Diagnosis Treatment, VTenth

← 1 2 →